data_1omb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1omb _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.454 -0.572 . . . . 1.51 109.454 . 69.41 -179.454 -101.802 104.274 2.021 104.231 103.857 -116.264 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 11' ' ' LYS . 26.3 mt -103.22 86.31 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 1.44 109.368 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.46 11.37 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 1.61 109.646 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -88.68 161.09 17.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 2.28 109.378 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.73 132.12 36.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 2.46 109.413 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 7.1 m-85 58.64 16.51 4.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 2.5 109.622 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.11 136.22 42.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.374 -1.49 . . . . 0.72 109.374 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' HD11 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -57.23 146.49 28.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -1.17 . . . . 3.74 109.407 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.0 p -142.57 -169.63 3.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.95 109.832 179.979 64.647 -158.796 -138.698 104.04 2.019 104.349 -152.261 -119.927 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -150.11 138.04 20.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.539 -0.726 . . . . 1.87 109.172 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -70.22 97.66 1.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 3.34 109.413 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.63 -6.67 29.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.58 109.485 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.54 -128.61 5.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.41 . . . . 1.14 109.576 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -70.5 114.37 8.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 1.7 109.683 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.8 ttmt -92.66 167.56 11.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 3.49 109.338 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -70.42 140.74 52.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 1.16 109.512 -179.978 -134.504 149.415 -106.458 104.112 2.021 104.093 169.788 171.713 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -58.41 148.25 28.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 1.9 109.343 -179.999 -116.264 103.857 -101.802 104.231 2.021 104.274 -179.454 69.41 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER 83.28 -41.92 0.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.663 -0.648 . . . . 5.43 109.945 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.36 63.86 0.32 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 1.73 109.508 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.76 141.06 22.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 3.78 109.44 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.34 140.85 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.13 1.887 . . . . 1.27 110.003 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.48 126.63 48.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 1.27 109.245 179.977 -119.927 -152.261 -138.698 104.349 2.019 104.04 -158.796 64.647 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 160.21 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 4.2 109.917 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 75.9 m -129.95 -178.62 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -0.804 . . . . 1.2 109.353 179.961 -58.844 -84.036 107.011 104.244 2.02 104.213 -103.492 -58.174 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' MET . 5.4 m -95.31 33.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 3.13 109.533 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 62.79 11.99 5.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 4.85 109.523 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 28' ' ' SER . 2.6 pt -125.84 -8.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 4.37 109.629 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 52.97 18.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.418 -1.473 . . . . 3.3 109.418 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -134.16 -87.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -1.153 . . . . 3.83 109.574 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.76 90.07 8.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 3.19 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 68.5 m -92.8 121.38 34.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 1.31 109.386 179.993 -58.174 -103.492 107.011 104.213 2.02 104.244 -84.036 -58.844 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.72 146.74 27.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.226 -0.921 . . . . 2.28 109.552 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 22.1 t -75.27 132.7 41.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.94 109.427 179.997 171.713 169.788 -106.458 104.093 2.021 104.112 149.415 -134.504 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.93 130.07 23.42 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 1.6 109.273 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.312 -1.376 0 C-N-CA 121.96 1.773 . . . . 1.18 110.194 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.454 -0.572 . . . . 1.51 109.454 . 69.41 -179.454 -101.802 104.274 2.021 104.231 103.857 -116.264 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 11' ' ' LYS . 26.3 mt -103.22 86.31 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 0.85999999999999999 109.368 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.46 11.37 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 1.1000000000000001 109.646 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -88.68 161.09 17.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 2.2799999999999998 109.378 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.73 132.12 36.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 2.46 109.413 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.1 m-85 58.64 16.51 4.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 1.71 109.622 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.11 136.22 42.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.374 -1.49 . . . . 0.71999999999999997 109.374 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -57.23 146.49 28.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -1.17 . . . . 3.3700000000000001 109.407 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.0 p -142.57 -169.63 3.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.94999999999999996 109.832 179.979 64.647 -158.796 -138.698 104.04 2.019 104.349 -152.261 -119.927 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -150.11 138.04 20.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.539 -0.726 . . . . 1.4399999999999999 109.172 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -70.22 97.66 1.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 2.7999999999999998 109.413 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.63 -6.67 29.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.5800000000000001 109.485 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.54 -128.61 5.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -70.5 114.37 8.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 1.29 109.683 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.8 ttmt -92.66 167.56 11.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 3.0600000000000001 109.338 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -70.42 140.74 52.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 1.1299999999999999 109.512 -179.978 -134.504 149.415 -106.458 104.112 2.021 104.093 169.788 171.713 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -58.41 148.25 28.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 1.8999999999999999 109.343 -179.999 -116.264 103.857 -101.802 104.231 2.021 104.274 -179.454 69.41 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER 83.28 -41.92 0.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.663 -0.648 . . . . 4.7400000000000002 109.945 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.36 63.86 0.32 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 1.3200000000000001 109.508 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.76 141.06 22.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 3.1499999999999999 109.44 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.34 140.85 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.13 1.887 . . . . 1.0600000000000001 110.003 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.48 126.63 48.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 1.27 109.245 179.977 -119.927 -152.261 -138.698 104.349 2.019 104.04 -158.796 64.647 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 160.21 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 3.6099999999999999 109.917 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 75.9 m -129.95 -178.62 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -0.804 . . . . 1.2 109.353 179.961 -58.844 -84.036 107.011 104.244 2.02 104.213 -103.492 -58.174 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' HG12 ' A' ' 30' ' ' ILE . 5.4 m -95.31 33.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 2.6099999999999999 109.533 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 62.79 11.99 5.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 4.5099999999999998 109.523 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 28' ' ' SER . 2.6 pt -125.84 -8.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 3.9199999999999999 109.629 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 52.97 18.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.418 -1.473 . . . . 3.2999999999999998 109.418 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -134.16 -87.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -1.153 . . . . 3.27 109.574 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.76 90.07 8.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 2.71 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 68.5 m -92.8 121.38 34.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 1.1100000000000001 109.386 179.993 -58.174 -103.492 107.011 104.213 2.02 104.244 -84.036 -58.844 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.72 146.74 27.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.226 -0.921 . . . . 2.2799999999999998 109.552 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 22.1 t -75.27 132.7 41.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.93999999999999995 109.427 179.997 171.713 169.788 -106.458 104.093 2.021 104.112 149.415 -134.504 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.93 130.07 23.42 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 1.1200000000000001 109.273 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.312 -1.376 0 C-N-CA 121.96 1.773 . . . . 1.1599999999999999 110.194 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.454 -0.572 . . . . 1.51 109.454 . 69.41 -179.454 -101.802 104.274 2.021 104.231 103.857 -116.264 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.455 HD13 ' O ' ' A' ' 11' ' ' LYS . 26.3 mt -103.22 86.31 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 0.86 109.368 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.46 11.37 28.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 1.1 109.646 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -88.68 161.09 17.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 2.28 109.378 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.73 132.12 36.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 2.46 109.413 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 7.1 m-85 58.64 16.51 4.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 1.71 109.622 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.11 136.22 42.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.374 -1.49 . . . . 0.72 109.374 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -57.23 146.49 28.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -1.17 . . . . 3.37 109.407 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 32.0 p -142.57 -169.63 3.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.95 109.832 179.979 64.647 -158.796 -138.698 104.04 2.019 104.349 -152.261 -119.927 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 m -150.11 138.04 20.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.539 -0.726 . . . . 1.44 109.172 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -70.22 97.66 1.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 2.8 109.413 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.63 -6.67 29.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.485 -1.446 . . . . 1.58 109.485 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.54 -128.61 5.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.576 -1.41 . . . . 1.0 109.576 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 m -70.5 114.37 8.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -1.137 . . . . 1.29 109.683 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 19' ' ' CYS . 20.8 ttmt -92.66 167.56 11.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 3.06 109.338 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -70.42 140.74 52.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.445 -0.784 . . . . 1.13 109.512 -179.978 -134.504 149.415 -106.458 104.112 2.021 104.093 169.788 171.713 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -58.41 148.25 28.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.167 -0.958 . . . . 1.9 109.343 -179.999 -116.264 103.857 -101.802 104.231 2.021 104.274 -179.454 69.41 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER 83.28 -41.92 0.1 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.663 -0.648 . . . . 4.74 109.945 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.36 63.86 0.32 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.508 -1.437 . . . . 1.32 109.508 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.76 141.06 22.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.299 -1.118 . . . . 3.15 109.44 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.34 140.85 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.13 1.887 . . . . 1.06 110.003 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.48 126.63 48.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 1.27 109.245 179.977 -119.927 -152.261 -138.698 104.349 2.019 104.04 -158.796 64.647 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.49 160.21 15.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.352 -0.843 . . . . 3.61 109.917 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 75.9 m -129.95 -178.62 4.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.414 -0.804 . . . . 1.2 109.353 179.961 -58.844 -84.036 107.011 104.244 2.02 104.213 -103.492 -58.174 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.478 ' O ' HG12 ' A' ' 30' ' ' ILE . 5.4 m -95.31 33.7 1.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.253 -0.905 . . . . 2.61 109.533 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 28' ' ' SER . 0.0 OUTLIER 62.79 11.99 5.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 4.51 109.523 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 28' ' ' SER . 2.6 pt -125.84 -8.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 3.92 109.629 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.5 52.97 18.78 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.418 -1.473 . . . . 3.3 109.418 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 p -134.16 -87.31 0.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -1.153 . . . . 3.27 109.574 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.76 90.07 8.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 2.71 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 68.5 m -92.8 121.38 34.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 1.11 109.386 179.993 -58.174 -103.492 107.011 104.213 2.02 104.244 -84.036 -58.844 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.72 146.74 27.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.226 -0.921 . . . . 2.28 109.552 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 22.1 t -75.27 132.7 41.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.94 109.427 179.997 171.713 169.788 -106.458 104.093 2.021 104.112 149.415 -134.504 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.93 130.07 23.42 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 1.12 109.273 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 C--N 1.312 -1.376 0 C-N-CA 121.96 1.773 . . . . 1.16 110.194 -179.998 . . . . . . . . 0 0 . 1 stop_ save_